Patient Capital Management’s Splunk Inc SPLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-290,196
Closed -$42.4M 46
2023
Q3
$42.4M Sell
290,196
-144,410
-33% -$16.4M 2.49% 19
2023
Q2
$46.1M Buy
434,606
+381,606
+720% +$36.3M 2.57% 19
2023
Q1
$5.08M Hold
53,000
2.26% 21
2022
Q4
$4.56M Buy
53,000
+5,425
+11% +$438K 2.22% 23
2022
Q3
$3.58M Sell
47,575
-1,825
-4% -$179K 1.79% 27
2022
Q2
$4.37M Buy
49,400
+3,900
+9% +$429K 1.94% 25
2022
Q1
$6.76M Sell
45,500
-12,200
-21% -$1.49M 2.29% 20
2021
Q4
$6.68M Buy
+57,700
New +$8.06M 1.92% 22

Other funds holding SPLK

Patient Capital Management's SPLK Position: Q4 2023 in Review

Patient Capital Management sold out of Splunk Inc (SPLK) in Q4 2023, closing a stake of 290,196 shares — an estimated $42.4M sold.

Patient Capital Management first reported a position in SPLK in Q4 2021 and held it in 8 quarters. The position peaked at $46.1M in Q2 2023. 683 funds tracked by Wall St. Rank hold SPLK as of Q4 2023.

  • Patient Capital Management reported no remaining Splunk Inc position as of Q4 2023 after selling out during the quarter.
  • Patient Capital Management sold 290,196 Splunk Inc shares in Q4 2023, an estimated $42.4M.
  • Patient Capital Management first reported a position in Splunk Inc in Q4 2021 and held it in 8 quarters.
  • Patient Capital Management's Splunk Inc position peaked at $46.1M in Q2 2023.
  • 683 funds tracked by Wall St. Rank held Splunk Inc as of Q4 2023.

Based on Patient Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.